arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2503.03410eess.IVcs.AIcs.CV
收藏

基于增强的深度学习用于循环肿瘤细胞的识别

Augmentation-Based Deep Learning for Identification of Circulating Tumor Cells

Institute for High Performance Computing and Networking-National Research Council of Italy (ICAR-CNR)(高性能计算与网络研究所-意大利国家研究理事会)

Martina Russo, Giulia Bertolini, Vera Cappelletti, Cinzia De Marco, Serena Di Cosimo, Petra Paiè, Nadia Brancati

AI总结:

本研究提出基于深度学习的CTC识别方法,利用明场图像和数据增强技术提升诊断准确性,实现无荧光标记的CTC检测。

摘要:

循环肿瘤细胞(CTCs)是液体活检中的关键生物标志物,提供了一种无创的癌症患者管理工具。然而,由于其数量有限和异质性,其识别尤其具有挑战性。对样本进行标记限制了基于荧光的方法在不同医院数据集上的泛化能力。分析单细胞图像可以详细评估细胞形态、亚细胞结构和表型变异,这些信息通常隐藏在聚类图像中。开发基于明场单细胞分析的方法可以克服这些限制。CTCs可以通过结合Parsortix技术的无偏工作流程进行分离,该技术根据大小和变形性选择细胞,与DEPArray技术结合,能够实现对单细胞的精确可视化和选择。传统上,DEPArray获取的数字图像需要手动分析,使过程耗时且易受变异性影响。在本研究中,我们提出了一种基于深度学习的分类管道,旨在区分血液样本中的CTCs和白细胞,以提高诊断准确性和优化临床工作流程。我们的方法利用通过DEPArray技术获得的明场通道图像,结合基于ResNet的CNN。为了提高模型泛化能力,我们应用了三种类型的数据增强技术,并在训练阶段加入了荧光(DAPI)通道图像,使网络能够学习额外的CTC特异性特征。值得注意的是,仅使用明场图像进行测试,确保模型能够识别CTCs而不依赖荧光标记。所提出的模型实现了0.798的F1分数,证明了其区分CTCs和白细胞的能力。这些发现突显了深度学习在优化CTC分析和推进液体活检应用中的潜力。

英文摘要:

Circulating tumor cells (CTCs) are crucial biomarkers in liquid biopsy, offering a noninvasive tool for cancer patient management. However, their identification remains particularly challenging due to their limited number and heterogeneity. Labeling samples for contrast limits the generalization of fluorescence-based methods across different hospital datasets. Analyzing single-cell images enables detailed assessment of cell morphology, subcellular structures, and phenotypic variations, often hidden in clustered images. Developing a method based on bright-field single-cell analysis could overcome these limitations. CTCs can be isolated using an unbiased workflow combining Parsortix technology, which selects cells based on size and deformability, with DEPArray technology, enabling precise visualization and selection of single cells. Traditionally, DEPArray-acquired digital images are manually analyzed, making the process time-consuming and prone to variability. In this study, we present a Deep Learning-based classification pipeline designed to distinguish CTCs from leukocytes in blood samples, aimed to enhance diagnostic accuracy and optimize clinical workflows. Our approach employs images from the bright-field channel acquired through DEPArray technology leveraging a ResNet-based CNN. To improve model generalization, we applied three types of data augmentation techniques and incorporated fluorescence (DAPI) channel images into the training phase, allowing the network to learn additional CTC-specific features. Notably, only bright-field images have been used for testing, ensuring the model's ability to identify CTCs without relying on fluorescence markers. The proposed model achieved an F1-score of 0.798, demonstrating its capability to distinguish CTCs from leukocytes. These findings highlight the potential of DL in refining CTC analysis and advancing liquid biopsy applications.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑